Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ischemic stroke after use of the synthetic marijuana “spice”
Melissa Freeman, David Z. Rose, Martin Myers, et al.
Neurology (2013) Vol. 81, Iss. 24, pp. 2090-2093
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Marisol S. Castaneto, David A. Gorelick, Nathalie A. Desrosiers, et al.
Drug and Alcohol Dependence (2014) Vol. 144, pp. 12-41
Open Access | Times Cited: 657
Novel psychoactive substances of interest for psychiatry
Fabrizio Schifano, Laura Orsolini, Gabriele Duccio Papanti, et al.
World Psychiatry (2015) Vol. 14, Iss. 1, pp. 15-26
Open Access | Times Cited: 303
Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 212
Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States
Kavelin Rumalla, Adithi Y. Reddy, Manoj Mittal
Journal of the Neurological Sciences (2016) Vol. 364, pp. 191-196
Closed Access | Times Cited: 152
Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke
Valérie Wolff, Anna-Isabel Schlagowski, Olivier Rouyer, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-7
Open Access | Times Cited: 128
What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review
Émilie Jouanjus, Valentin Raymond, Maryse Lapeyre‐Mestre, et al.
Current Atherosclerosis Reports (2017) Vol. 19, Iss. 6
Closed Access | Times Cited: 127
A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse
Aristides Tsatsakis, Anca Oana Docea, Daniela Călina, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1295-1295
Open Access | Times Cited: 123
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices
Marisol S. Castaneto, Ariane Wohlfarth, Nathalie A. Desrosiers, et al.
Drug Metabolism Reviews (2015) Vol. 47, Iss. 2, pp. 124-174
Closed Access | Times Cited: 108
Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues
L.J. Schep, Robin J Slaughter, Simon Hudson, et al.
Human & Experimental Toxicology (2014) Vol. 34, Iss. 5, pp. 557-560
Closed Access | Times Cited: 99
New/emerging psychoactive substances and associated psychopathological consequences
Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, et al.
Psychological Medicine (2019) Vol. 51, Iss. 1, pp. 30-42
Open Access | Times Cited: 94
Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review
M. Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, et al.
Brain Sciences (2023) Vol. 13, Iss. 7, pp. 990-990
Open Access | Times Cited: 31
Strokes are possible complications of cannabinoids use
Valérie Wolff, Émilie Jouanjus
Epilepsy & Behavior (2017) Vol. 70, pp. 355-363
Closed Access | Times Cited: 85
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid
Mai Takematsu, Robert S. Hoffman, Lewis S. Nelson, et al.
Clinical Toxicology (2014) Vol. 52, Iss. 9, pp. 973-975
Closed Access | Times Cited: 83
Adverse Health Effects of Marijuana Use
George R. Thompson, Joseph M. Tuscano
New England Journal of Medicine (2014) Vol. 371, Iss. 9, pp. 878-879
Closed Access | Times Cited: 83
Toxicology and Management of Novel Psychoactive Drugs
Brian Kersten, Megan McLaughlin
Journal of Pharmacy Practice (2014) Vol. 28, Iss. 1, pp. 50-65
Closed Access | Times Cited: 81
Characteristics and circumstances of synthetic cannabinoid-related death
Shane Darke, Johan Duflou, Michael Farrell, et al.
Clinical Toxicology (2019) Vol. 58, Iss. 5, pp. 368-374
Closed Access | Times Cited: 75
Molecular Mechanism and Cannabinoid Pharmacology
Lesley D. Schurman, Dai Lu, Debra A. Kendall, et al.
Handbook of experimental pharmacology (2019), pp. 323-353
Open Access | Times Cited: 73
Synthetic cannabinoids 2015: An update for pediatricians in clinical practice
Daniel Castellanos
World Journal of Clinical Pediatrics (2016) Vol. 5, Iss. 1, pp. 16-16
Open Access | Times Cited: 61
Hemorrhagic stroke following use of the synthetic marijuana “spice”
David Z. Rose, Waldo R. Guerrero, Maxim Mokin, et al.
Neurology (2015) Vol. 85, Iss. 13, pp. 1177-1179
Open Access | Times Cited: 54
Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset
Giovanni Martinotti, Rita Santacroce, Duccio Papanti, et al.
CNS & Neurological Disorders - Drug Targets (2017) Vol. 16, Iss. 5
Open Access | Times Cited: 54
Understanding the risks associated with the use of new psychoactive substances (NPS): High variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products
Luca Zamengo, Giampietro Frison, Chiara Bettin, et al.
Toxicology Letters (2014) Vol. 229, Iss. 1, pp. 220-228
Closed Access | Times Cited: 52
Adverse effects after the use of JWH‐210 – a case series from the EU Spice II plus project
Maren Hermanns‐Clausen, Josephine Kithinji, Marco S. Spehl, et al.
Drug Testing and Analysis (2016) Vol. 8, Iss. 10, pp. 1030-1038
Closed Access | Times Cited: 51
The Synthetic Cannabinoids Phenomenon
Laurent Karila, Amine Benyamina, Lisa Blecha, et al.
Current Pharmaceutical Design (2016) Vol. 22, Iss. 42, pp. 6420-6425
Closed Access | Times Cited: 51
Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events
Colin Davidson, Jolanta Opacka‐Juffry, Ángel Arévalo‐Martín, et al.
Advances in pharmacology (2017), pp. 135-168
Closed Access | Times Cited: 49
Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective
Sabrina Rahman Archie, Luca Cucullo
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top